posted on 2015-02-18, 00:00authored byJeff Henise, Brian R. Hearn, Gary W. Ashley, Daniel V. Santi
We have developed an approach to
prepare drug-releasing Tetra-PEG
hydrogels with exactly four cross-links per monomer. The gels contain
two cleavable β-eliminative linkers: one for drug attachment
that releases the drug at a predictable rate, and one with a longer
half-life placed in each cross-link to control biodegradation. Thus,
the system can be optimized to release the drug before significant
gel degradation occurs. The synthetic approach involves placing a
heterobifunctional connector at each end of a four-arm PEG prepolymer;
four unique end-groups of the resultant eight-arm prepolymer are used
to tether a linker-drug, and the other four are used for polymerization
with a second four-arm PEG. Three different orthogonal reactions that
form stable triazoles, diazines, or oximes have been used for tethering
the drug to the PEG and for cross-linking the polymer. Three formats
for preparing hydrogel–drug conjugates are described that either
polymerize preformed PEG–drug conjugates or attach the drug
postpolymerization. Degradation of drug-containing hydrogels proceeds
as expected for homogeneous Tetra-PEG gels with minimal degradation
occurring in early phases and sharp, predictable reverse gelation
times. The minimal early degradation allows design of gels that show
almost complete drug release before significant gel-drug fragments
are released.